Acquisition Synergies Leverage ILC Dover ownership to access an expanded network of biopharma, cell & gene therapy, tissue banking, and medical device customers, positioning KSE as the preferred sterile WFI and media supplier to streamline procurement and regulatory-aligned supply chains.

WFI Market Expansion Target growth by expanding Water for Injection and related media offerings to CDMOs, contract manufacturers, and research labs, emphasizing validated sterile processes, scalable production, and rapid onboarding.

Quality Compliance Differentiate with robust quality systems, traceability, and sterile manufacturing controls to support audits and regulatory readiness, enabling upsell of services and long-term partnerships.

Strategic Partnerships Develop channel partnerships with bioprocess equipment suppliers and distributors, offering bundled solutions that combine sterile media with containment or device offerings to win larger contracts.

Lean Customization Leverage a lean team to offer customized WFI formulations and on-demand buffering solutions with rapid quotes and flexible fulfillment for niche markets.